Flowserve swing check valves help increase reliability in chemical applications

Published: 5-Mar-2010
Manufacturing

Redesigned Flowserve Noble Alloy swing check valve offers corrosion resistance and high reliability

Flowserve Corporation, a leading provider of flow control products and services for the global infrastructure markets, today introduced the redesigned Flowserve Noble Alloy swing check valve, which offers corrosion resistance and high reliability in severe service chemical applications.

The new design introduces casting technology in lieu of forgings, which reduces the weight of the valve by 45% and offers enhanced bonnet-seal performance. The valve features a recessed hinge pin that is protected from the flow path, integral seat design and a high integrity riveted disc assembly. The valve can be installed horizontally or vertically.

'Flowserve's foundry specialises in the alloys and highly engineered casting processes that helped to create the redesigned Noble Alloy swing check valve,' said Brian Hood, product manager, Flowserve Flow Control Division. 'Even in the most challenging applications, this valve delivers improved performance for customers" most severe applications while helping reduce life-cycle costs.'

The Noble Alloy swing check valve is available with soft or metal seating. It features multiple end connections and bolted bonnet construction.

Noble Alloy also offers a wafer piston check design in cast and forged technology. Forged metal construction remains available for all Noble Alloy valve designs.
See more

You may also like

Training & Education

Flowserve opens training centre in Italy

Read more
Adds to global network of Learning Resource Centres

Trending Articles

  1. UK pharma shifts as Merck and AstraZeneca scale back: can CDMOs fill the gap? Recent major site withdrawals and investment pauses have raised concerns about the UK’s industrial strength. But CDMOs say agility, innovation and technical expertise could redefine how and where drugs are made
  2. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  3. Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma Executive with over 20 years of management experience to lead pharmaceutical packaging and delivery systems company
  4. Abzena and Mabqi announce strategic partnership to offer integrated discovery through development solution This collaboration will integrate Mabqi’s antibody discovery capabilities with Abzena’s development and manufacturing services, offering biopharma customers a more streamlined, end-to-end drug development solution
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    The cross-pollination effect: how shared learnings bear fruit for drug sponsors This article explores how contract development and manufacturing organisations leverage the cross-pollination of knowledge to help drug sponsors overcome critical challenges in pharmaceutical development

You may also like

Training & Education

Flowserve opens training centre in Italy

Adds to global network of Learning Resource Centres
Manufacturing

New Flowserve digital positioner features predictive diagnostics

Flowserve Corporation, a leading provider of flow control products and services for the global infrastructure markets, has announced the release of the Flowserve Logix 3400MD, the newest member of the Logix series digital positioner family
Manufacturing

Pioneering Peptide-Builder debuts at UEA

Vapourtec kept it local with the first ever installation of their pioneering production Peptide-Builder system taking place at the University of East Anglia (UEA) in Norwich
Manufacturing

Moderna invests $140m to onshore drug product manufacturing and complete US end-to-end mRNA network

Moderna is expanding its Norwood, Massachusetts site to bring drug product manufacturing in-house, creating hundreds of biomanufacturing jobs and establishing full domestic, end-to-end production for its mRNA vaccines and therapeutics by 2027
Manufacturing

GEA to showcase Rockwell Automation-Compatible GEA kytero 2000 Single-Use Separator at Automation Fair 2025

As a gold-level OEM member of the Rockwell PartnerNetwork™, GEA is strengthening its collaboration with Rockwell by offering full compatibility between the kytero® 2000 and Rockwell’s latest hardware and software suite
Manufacturing

SU Puresonic ultrasonic sensor ensures precise hygienic flow measurement

Innovative design meets the highest standards in food, pharma, and water treatment
Manufacturing

Breaking down silos and building in seamless scale

A Q&A with Kindeva's Tommy Schornak on the Bridgeton facility, Annex 1 compliance and scaling sterile injectable production
Subscribe now